JNJ — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates JNJ as Bearish with 79% confidence in the Healthcare sector.
AI Analysis Summary
Johnson & Johnson (JNJ) presents significant downside risk due to overvaluation, high leverage, and deteriorating earnings, despite defensive characteristics.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade C — 58/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Bearish
Price Intelligence
- Current price: $227.50
- Price target: $197.00 (-13.4%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: fair
- Competitive moat: brand power
Peer Group Analysis
JNJ is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.